Abstract
Objectives: In this paper, we address the questions: how large a sample size would be required to show genome-wide significance between a single nucleotide polymorphism (SNP) and a genetic trait in a meta-analysis of a newly planned study together with the existing ones? Or alternatively: will a planned study of size n be able to provide evidence of a genetic association when this study is combined with a current meta-analysis? Methods: We examine the potential impact of a newly planned genetic study on an existing meta-analysis through the use of a simulation-based algorithm. The proposed approach provides an empirical estimate of the power of the updated meta-analysis to detect genome-wide significance (p < 5.0 × 10<sup>-8</sup>) of a complex trait and each of a set of specific SNPs of interest or the expected p value of the updated meta-analysis including the current and proposed studies. Results: This technique is illustrated in the context of an updated meta-analysis of case-control studies in Paget's disease. A second example illustrates the impact of adding a newly planned study to a large meta-analysis of SNP associations with human height. Conclusions: The proposed algorithm is particularly useful for the design of studies to assess a selected set of high-priority SNP associations that are ‘nearly' significant in meta-analysis of existing studies. The results may help investigators decide whether an updated meta-analysis is likely to achieve genome-wide significance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have